{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:36:02Z","timestamp":1792092962489,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jaip.2025.09.038","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:15:27Z","timestamp":1759997727000},"page":"475-481.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Omalizumab Enables Bee Venom Desensitization in Patients With Anaphylactic Reactions to Venom Immunotherapy"],"prefix":"10.1016","volume":"14","author":[{"given":"Kris","family":"Capper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"McGettigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cate","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.09.038_bib1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0091-6749(72)90045-0","article-title":"Frequency of Hymenoptera allergy in an atopic and normal population","volume":"50","author":"Settipane","year":"1972","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.038_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM197807272990401","article-title":"A controlled trial of immunotherapy in insect hypersensitivity","volume":"299","author":"Hunt","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.09.038_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-017-0204-y","article-title":"Safety of 100 \u03bcg venom immunotherapy rush protocols in children compared to adults","volume":"13","author":"Stoevesandt","year":"2017","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.038_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00003495-200161020-00008","article-title":"Omalizumab","volume":"61","author":"Easthope","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.jaip.2025.09.038_bib5","first-page":"225","article-title":"Failure of omalizumab treatment after recurrent systemic reactions to bee-venom immunotherapy","volume":"18","author":"Soriano Gomis","year":"2008","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.038_bib6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1398-9995.2007.01604.x","article-title":"High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis","volume":"63","author":"Kontou-Fili","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.09.038_bib7","first-page":"225","article-title":"Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab","volume":"19","author":"Galera","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.038_bib8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jaip.2013.07.004","article-title":"Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome","volume":"1","author":"da Silva","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.09.038_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12948-016-0051-2","article-title":"Dose-dependence of protection from systemic reactions to venom immunotherapy by omalizumab","volume":"14","author":"Boni","year":"2016","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.jaip.2025.09.038_bib10","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/cea.12997","article-title":"Overcoming severe adverse reactions to venom immunotherapy using anti-IgE antibodies in combination with a high maintenance dose","volume":"47","author":"Stretz","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.09.038_bib11","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.5415\/apallergy.2018.8.e2","article-title":"Combination of omalizumab and bee venom immunotherapy: does it work?","volume":"8","author":"Y\u0131lmaz","year":"2018","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.jaip.2025.09.038_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.alit.2018.09.003","article-title":"Efficacy of a short pretreatment with omalizumab in children with anaphylaxis to hymenoptera venom immunotherapy: a report of three cases","volume":"68","author":"Droitcourt","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2025.09.038_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5414\/ALX02196E","article-title":"Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis","volume":"5","author":"G\u00fclsen","year":"2021","journal-title":"Allergol Select"},{"key":"10.1016\/j.jaip.2025.09.038_bib14","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.55730\/1300-0144.5427","article-title":"Venom immunotherapy and difficulties encountered before and during immunotherapy: double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT","volume":"52","author":"\u00c7etin","year":"2022","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.jaip.2025.09.038_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.038_bib17","first-page":"993","article-title":"Omalizumab (Xolair). Product description [in Danish]","volume":"169","author":"Laursen","year":"2007","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.jaip.2025.09.038_bib18","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/j.jaip.2021.03.005","article-title":"The genetic basis and clinical impact of hereditary alpha-tryptasemia","volume":"9","author":"Luskin","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.09.038_bib19","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaip.2015.12.002","article-title":"Monitoring allergic patients on omalizumab with free and total serum IgE measurements","volume":"4","author":"Hamilton","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.09.038_bib20","doi-asserted-by":"crossref","first-page":"AB202","DOI":"10.1016\/j.jaci.2009.12.791","article-title":"Venom immunotherapy efficacy monitoring by means of basophil activation test","volume":"125","author":"Trabado","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.038_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaip.2024.08.025","article-title":"Risk factors for severe sting reactions and side effects during venom immunotherapy","volume":"13","author":"Sturm","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.09.038_bib22","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJMoa2312382","article-title":"Omalizumab for the treatment of multiple food allergies","volume":"390","author":"Wood","year":"2024","journal-title":"N Engl J Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825009353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825009353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:35:22Z","timestamp":1780126522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825009353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2213219825009353"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.09.038","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omalizumab Enables Bee Venom Desensitization in Patients With Anaphylactic Reactions to Venom Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}